Literature DB >> 11965534

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.

Asra Mirza1, Marnie McGuirk, Tish N Hockenberry, Qun Wu, Hena Ashar, Stuart Black, Shu Fen Wen, Luquan Wang, Paul Kirschmeier, W Robert Bishop, Loretta L Nielsen, Cecil B Pickett, Suxing Liu.   

Abstract

Survivin is an inhibitor of apoptosis protein, which is over-expressed in most tumors. Aberrant expression of survivin and loss of wild-type p53 in many tumors prompted us to investigate a possible link between these two events. Here we show that wild-type p53 represses survivin expression at both mRNA and protein levels. Transient transfection analyses revealed that the expression of wild-type p53, but not mutant p53, was associated with strong repression of the survivin promoter in various cell types. The over-expression of exogenous survivin protein rescues cells from p53-induced apoptosis in a dose-dependent manner, suggesting that loss of survivin mediates, at least, in part the p53-dependent apoptotic pathway. In spite of the presence of two putative p53-binding sites in the survivin promoter, deletion and mutation analyses suggested that neither site is required for transcriptional repression of survivin expression. This was confirmed by chromatin immunoprecipitation assays. Further analyses suggested that the modification of chromatin within the survivin promoter could be a molecular explanation for silencing of survivin gene transcription by p53.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11965534     DOI: 10.1038/sj.onc.1205353

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  191 in total

Review 1.  Survivin and leukemia.

Authors:  Xiu Li Cong; Zhong Chao Han
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

2.  The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability.

Authors:  Elizabeth T Chang; James M Donahue; Lan Xiao; Yuhong Cui; Jaladanki N Rao; Douglas J Turner; William S Twaddell; Jian-Ying Wang; Richard J Battafarano
Journal:  Biochem J       Date:  2012-08-15       Impact factor: 3.857

3.  Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity.

Authors:  Jianguo Wu; Xiang Ling; Dalin Pan; Pasha Apontes; Lei Song; Ping Liang; Dario C Altieri; Terry Beerman; Fengzhi Li
Journal:  J Biol Chem       Date:  2005-01-05       Impact factor: 5.157

4.  Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

Authors:  Carol Imbriano; Aymone Gurtner; Fabienne Cocchiarella; Silvia Di Agostino; Valentina Basile; Monica Gostissa; Matthias Dobbelstein; Giannino Del Sal; Giulia Piaggio; Roberto Mantovani
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Characterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues.

Authors:  B Spaulding; D Pan; A Ghadersohi; G Nielsen; S Jensen; F Gellert; X Ling; M Zhang; A Black; F Li
Journal:  Histopathology       Date:  2006-12       Impact factor: 5.087

Review 6.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

7.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.

Authors:  Amjad Ali; Muhammad Zeeshan Bhatti; Abdus Saboor Shah; Hong-Quan Duong; Huda Mohammad Alkreathy; Shah Faisal Mohammad; Rahmat Ali Khan; Ayaz Ahmad
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

10.  Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer.

Authors:  Chan H Han; Qingyi Wei; Karen K Lu; Zhensheng Liu; Gordon B Mills; Li-E Wang
Journal:  Int J Clin Exp Med       Date:  2009-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.